首页 > 最新文献

Kurume Medical Journal最新文献

英文 中文
Discovery of Feeding Regulatory Peptides and The Importance of Peptide Discovery Research. 饲养调节肽的发现及肽发现研究的重要性。
Q4 Medicine Pub Date : 2025-11-13 Epub Date: 2025-04-18 DOI: 10.2739/kurumemedj.MS7134001
Takanori Ida, Kazuma Matsui, Sayaka Nagata, Tomoya Nakamachi, Yuki Shiimura, Takahiro Sato, Masayasu Kojima

Bioactive peptides consist of multiple linked amino acids that are secreted from cells and act on specific receptors in order to transmit information from one cell to another. Through signal transduction, bioactive peptides regulate various physiological functions in the body, and the discovery of new bioactive peptides is therefore likely to lead to the development of various diagnostic and therapeutic agents. In this article, we have focused on the bioactive peptides that are known as feeding regulatory peptides. They are among the bioactive peptides discovered as ligands for G protein-coupled receptors (GPCRs), and we have reviewed their diverse functions. In addition, the status of structural analysis of GPCRs, which is necessary in the drug discovery process, and research on orphan GPCRs, for which new ligands are expected to be discovered in the future, is introduced to systematize modern peptide research and discuss future developments in bioactive peptide research.

生物活性肽由细胞分泌的多个连接的氨基酸组成,作用于特定的受体,以便将信息从一个细胞传递到另一个细胞。生物活性肽通过信号转导调节机体的各种生理功能,新的生物活性肽的发现有可能导致各种诊断和治疗药物的开发。在这篇文章中,我们关注的是被称为喂养调节肽的生物活性肽。它们是作为G蛋白偶联受体(gpcr)的配体而被发现的生物活性肽之一,我们对它们的多种功能进行了综述。此外,介绍了药物发现过程中所必需的gpcr结构分析的现状,以及未来有望发现新的配体的孤儿型gpcr的研究,以系统化现代肽研究,并讨论生物活性肽研究的未来发展。
{"title":"Discovery of Feeding Regulatory Peptides and The Importance of Peptide Discovery Research.","authors":"Takanori Ida, Kazuma Matsui, Sayaka Nagata, Tomoya Nakamachi, Yuki Shiimura, Takahiro Sato, Masayasu Kojima","doi":"10.2739/kurumemedj.MS7134001","DOIUrl":"10.2739/kurumemedj.MS7134001","url":null,"abstract":"<p><p>Bioactive peptides consist of multiple linked amino acids that are secreted from cells and act on specific receptors in order to transmit information from one cell to another. Through signal transduction, bioactive peptides regulate various physiological functions in the body, and the discovery of new bioactive peptides is therefore likely to lead to the development of various diagnostic and therapeutic agents. In this article, we have focused on the bioactive peptides that are known as feeding regulatory peptides. They are among the bioactive peptides discovered as ligands for G protein-coupled receptors (GPCRs), and we have reviewed their diverse functions. In addition, the status of structural analysis of GPCRs, which is necessary in the drug discovery process, and research on orphan GPCRs, for which new ligands are expected to be discovered in the future, is introduced to systematize modern peptide research and discuss future developments in bioactive peptide research.</p>","PeriodicalId":39559,"journal":{"name":"Kurume Medical Journal","volume":" ","pages":"89-109"},"PeriodicalIF":0.0,"publicationDate":"2025-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144023183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Painful Os Peroneum Syndrome: An Unusual Diagnosis. 腓骨肌疼痛综合征:一个不寻常的诊断。
Q4 Medicine Pub Date : 2025-11-13 Epub Date: 2025-06-13 DOI: 10.2739/kurumemedj.MS7134006
Pedro Henrique Segatt, José Luiz Masson DE Almeida Prado, Márcio Luís Duarte

The painful Os peroneum syndrome is subdivided into acute and chronic cases. The acute presentation is usually caused by trauma, most commonly a supination or inversion of the ankle, which consequently can lead to a fracture of the Os peroneum or even a rupture of the peroneus longus tendon. Furthermore, its chronic presentation comes as a result of recurrent foot injuries or even recovery from a fracture with calcification remodeling of this sesamoid bone. The problem of underdiagnosing this disease lies in the consequences attached to the remodeling of the peroneus longus tendon with its calcification, or even leading to a picture of tenosynovitis and subsequent tendon rupture. We report a 55-year-old female patient who complains of pain in the lateral region of her right foot for ten days. The right foot X-ray detected the presence of "Os peroneum." Magnetic resonance imaging (MRI) shows edematous ossification in the peroneus longus tendon compatible with Os peroneum and with swelling of the surrounding soft tissue and tendinopathy of the peroneus longus, precisely in the region indicated by the skin marker. The set of findings is compatible with painful Os peroneum syndrome. The patient was treated with a non-steroidal anti-inflammatory for five days with the resolution of symptoms.

疼痛性腓骨肌综合征又分为急性和慢性两种。急性表现通常是由外伤引起的,最常见的是踝关节旋后或内翻,因此可导致腓骨Os骨折,甚至腓骨长肌腱断裂。此外,其慢性表现是由于复发性足部损伤或甚至从骨折中恢复并伴有籽骨的钙化重塑。本病诊断不足的问题在于伴随腓骨长肌腱钙化重建的后果,甚至导致腱鞘炎和随后的肌腱断裂。我们报告了一位55岁的女性患者,她抱怨右脚外侧区域疼痛十天。右脚x光检查发现了“腓骨肌”磁共振成像(MRI)显示腓骨长肌腱水肿骨化,与腓骨Os相容,并伴有周围软组织肿胀和腓骨长肌腱病变,正是在皮肤标记所指示的区域。这组结果与疼痛性腓骨肌综合征相符。患者接受非甾体类抗炎药治疗5天,症状消退。
{"title":"Painful Os Peroneum Syndrome: An Unusual Diagnosis.","authors":"Pedro Henrique Segatt, José Luiz Masson DE Almeida Prado, Márcio Luís Duarte","doi":"10.2739/kurumemedj.MS7134006","DOIUrl":"10.2739/kurumemedj.MS7134006","url":null,"abstract":"<p><p>The painful Os peroneum syndrome is subdivided into acute and chronic cases. The acute presentation is usually caused by trauma, most commonly a supination or inversion of the ankle, which consequently can lead to a fracture of the Os peroneum or even a rupture of the peroneus longus tendon. Furthermore, its chronic presentation comes as a result of recurrent foot injuries or even recovery from a fracture with calcification remodeling of this sesamoid bone. The problem of underdiagnosing this disease lies in the consequences attached to the remodeling of the peroneus longus tendon with its calcification, or even leading to a picture of tenosynovitis and subsequent tendon rupture. We report a 55-year-old female patient who complains of pain in the lateral region of her right foot for ten days. The right foot X-ray detected the presence of \"Os peroneum.\" Magnetic resonance imaging (MRI) shows edematous ossification in the peroneus longus tendon compatible with Os peroneum and with swelling of the surrounding soft tissue and tendinopathy of the peroneus longus, precisely in the region indicated by the skin marker. The set of findings is compatible with painful Os peroneum syndrome. The patient was treated with a non-steroidal anti-inflammatory for five days with the resolution of symptoms.</p>","PeriodicalId":39559,"journal":{"name":"Kurume Medical Journal","volume":" ","pages":"153-156"},"PeriodicalIF":0.0,"publicationDate":"2025-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144303149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comminuted Transverse Femoral Shaft Fractures Are at Risk for Nonunion. 粉碎性股骨横轴骨折有发生骨不连的风险。
Q4 Medicine Pub Date : 2025-08-01 Epub Date: 2024-11-27 DOI: 10.2739/kurumemedj.MS7112005
Toru Matsugaki, Hideki Mizu-Uchi, Yuji Aratake, Keitarou Yasumoto

Background: The purpose of this study was to investigate the effect of the main fragment fracture type (oblique or transverse) on the union rate of femoral shaft fractures.

Methods: Patients who underwent surgical treatment with an antegrade intramedullary nail for femoral shaft fracture (Arbeitsgemeinschaft für Osteosynthesefragen / Orthopaedic Trauma Association; AO/OTA type 32 type B or C) between January 2009 and March 2021 were included in this study. Patients with oblique fractures of the two main fragments on radiographs immediately after surgery were classified into the oblique fracture group. Patients with at least one of the two main fractures being transverse fractures were classified into the transverse fracture group. We investigated age, sex, height, weight, body mass index (BMI), AO/OTA classification, time from fracture to surgery, intramedullary nail length and diameter, number of interlocking screws, and bone union rate.

Results: A total of 55 fractures were included. The mean age was 34.4 ± 16.7 (range, 16-77) years. There were 41 fractures classified into the oblique fracture group and 14 fractures classified into the transverse fracture group. There was a significantly higher proportion of men in the transverse fracture group. Patients in the transverse fracture group were significantly younger and taller. Only 1 of 41 (2.4%) patients in the oblique group experienced nonunion, while 3 of 14 (21.4%) patients in the transverse group experienced nonunion (p = 0.030).

Conclusion: Comminuted femoral shaft fractures with transverse fracture components are more prone to nonunion.

背景:本研究的目的是探讨主要碎片骨折类型(斜形或横形)对股骨干骨折愈合率的影响:本研究的目的是探讨主要碎片骨折类型(斜形或横形)对股骨干骨折愈合率的影响:本研究纳入了 2009 年 1 月至 2021 年 3 月期间接受股骨干骨折(Arbeitsgemeinschaft für Osteosynthesefragen / Orthopaedic Trauma Association;AO/OTA 32 型 B 或 C)前向髓内钉手术治疗的患者。术后即刻拍片显示两块主要骨折片为斜形骨折的患者被归入斜形骨折组。两块主要骨折中至少有一块为横向骨折的患者被归入横向骨折组。我们对患者的年龄、性别、身高、体重、体重指数(BMI)、AO/OTA 分级、骨折至手术时间、髓内钉长度和直径、联锁螺钉数量以及骨结合率进行了调查:结果:共纳入 55 例骨折患者。平均年龄为 34.4 ± 16.7(16-77)岁。其中 41 例骨折属于斜形骨折组,14 例骨折属于横形骨折组。横向骨折组中男性比例明显较高。横向骨折组的患者明显更年轻、更高。斜形骨折组的41名患者中只有1名(2.4%)出现了骨折不愈合,而横形骨折组的14名患者中有3名(21.4%)出现了骨折不愈合(P = 0.030):结论:带有横向骨折成分的股骨干粉碎性骨折更容易发生不愈合。
{"title":"Comminuted Transverse Femoral Shaft Fractures Are at Risk for Nonunion.","authors":"Toru Matsugaki, Hideki Mizu-Uchi, Yuji Aratake, Keitarou Yasumoto","doi":"10.2739/kurumemedj.MS7112005","DOIUrl":"10.2739/kurumemedj.MS7112005","url":null,"abstract":"<p><strong>Background: </strong>The purpose of this study was to investigate the effect of the main fragment fracture type (oblique or transverse) on the union rate of femoral shaft fractures.</p><p><strong>Methods: </strong>Patients who underwent surgical treatment with an antegrade intramedullary nail for femoral shaft fracture (Arbeitsgemeinschaft für Osteosynthesefragen / Orthopaedic Trauma Association; AO/OTA type 32 type B or C) between January 2009 and March 2021 were included in this study. Patients with oblique fractures of the two main fragments on radiographs immediately after surgery were classified into the oblique fracture group. Patients with at least one of the two main fractures being transverse fractures were classified into the transverse fracture group. We investigated age, sex, height, weight, body mass index (BMI), AO/OTA classification, time from fracture to surgery, intramedullary nail length and diameter, number of interlocking screws, and bone union rate.</p><p><strong>Results: </strong>A total of 55 fractures were included. The mean age was 34.4 ± 16.7 (range, 16-77) years. There were 41 fractures classified into the oblique fracture group and 14 fractures classified into the transverse fracture group. There was a significantly higher proportion of men in the transverse fracture group. Patients in the transverse fracture group were significantly younger and taller. Only 1 of 41 (2.4%) patients in the oblique group experienced nonunion, while 3 of 14 (21.4%) patients in the transverse group experienced nonunion (p = 0.030).</p><p><strong>Conclusion: </strong>Comminuted femoral shaft fractures with transverse fracture components are more prone to nonunion.</p>","PeriodicalId":39559,"journal":{"name":"Kurume Medical Journal","volume":" ","pages":"37-41"},"PeriodicalIF":0.0,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142740774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgical Treatment of Simultaneous Common Femoral and Profunda Femoris Artery Aneurysms. 同时发生的股总动脉和股深动脉动脉瘤的手术治疗。
Q4 Medicine Pub Date : 2025-08-01 Epub Date: 2024-11-27 DOI: 10.2739/kurumemedj.MS7112006
Yusuke Shintani, Satoru Tobinaga, Hiroyuki Saisho, Shigeaki Aoyagi, Eiki Tayama, Hiroshi Yasunaga

Profunda femoris artery aneurysms (PFAAs) are rare because of the histo-anatomical characteristics of the profunda femoris arteries. We present a case of simultaneous PFAA and common femoral artery aneurysm (CFAA) incidentally detected on computed tomography in a 58-year-old man with diverticular bleeding. Images revealed a 37-mm right PFAA and a 24-mm right CFAA. According to the report, PFAAs >20 mm are a surgical indication, and surgery should be decided based on the patient's general condition. We resected the aneurysms and reconstructed the arteries using vascular prostheses. The postoperative course was uneventful, and the patient was discharged 8 days postoperatively.

由于股底动脉的组织解剖特点,股底动脉瘤(PFAA)非常罕见。我们报告了一例同时患有股底动脉瘤和股总动脉瘤(CFAA)的病例,患者是一名 58 岁的男性,因憩室出血而在计算机断层扫描中意外发现。图像显示右侧有一个 37 毫米的 PFAA 和一个 24 毫米的右侧 CFAA。报告指出,PFAA>20 毫米是手术指征,应根据患者的全身情况决定是否手术。我们切除了动脉瘤,并使用血管假体重建了动脉。术后过程顺利,患者术后 8 天出院。
{"title":"Surgical Treatment of Simultaneous Common Femoral and Profunda Femoris Artery Aneurysms.","authors":"Yusuke Shintani, Satoru Tobinaga, Hiroyuki Saisho, Shigeaki Aoyagi, Eiki Tayama, Hiroshi Yasunaga","doi":"10.2739/kurumemedj.MS7112006","DOIUrl":"10.2739/kurumemedj.MS7112006","url":null,"abstract":"<p><p>Profunda femoris artery aneurysms (PFAAs) are rare because of the histo-anatomical characteristics of the profunda femoris arteries. We present a case of simultaneous PFAA and common femoral artery aneurysm (CFAA) incidentally detected on computed tomography in a 58-year-old man with diverticular bleeding. Images revealed a 37-mm right PFAA and a 24-mm right CFAA. According to the report, PFAAs >20 mm are a surgical indication, and surgery should be decided based on the patient's general condition. We resected the aneurysms and reconstructed the arteries using vascular prostheses. The postoperative course was uneventful, and the patient was discharged 8 days postoperatively.</p>","PeriodicalId":39559,"journal":{"name":"Kurume Medical Journal","volume":" ","pages":"75-78"},"PeriodicalIF":0.0,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142740876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of Hyperbaric Oxygen Therapy for Malignant Bowel Obstruction Caused by Peritoneal Dissemination. 高压氧疗法对腹膜扩散引起的恶性肠梗阻的影响
Q4 Medicine Pub Date : 2025-08-01 Epub Date: 2024-09-27 DOI: 10.2739/kurumemedj.MS7112001
Daisuke Muroya, Shoichiro Arai, Takamichi Nishida, Takahide Ishimaru, Yuta Yamazaki, Youjirou Goto, Shinya Nadayoshi, Yutaro Kai, Tetsu Masuda, Hisaaki Shimokobe, Yuichi Goto, Yuichi Nagao, Yoshito Wada, Takayuki Torigoe, Yoshinori Tomoda, Yuji Maruyama, Hajime Imada, Hironobu Sou, Yoshito Akagi, Toru Hisaka

Introduction: This study aimed to investigate the efficacy of hyperbaric oxygen therapy (HBOT) in patients presenting with malignant bowel obstruction (MBO) and peritoneal dissemination.

Materials and methods: We retrospectively examined whether HBOT affects prognosis following MBO with peritoneal dissemination. This study included 44 patients diagnosed with MBO secondary to peritoneal dissemination at our hospital between January 2013 and December 2022. Among these patients, 30 underwent HBOT. The treatment protocol involved daily HBOT administration, comprising 100% oxygen at 2.5 atmospheres absolute for 60 min.

Results: In a univariate analysis of HBOT and non-HBOT groups, the proportion of patients able to resume eating was significantly higher in the HBOT group. Therefore, the percentage of patients in the non-HBOT group whose MBO did not improve was significantly higher than that in the HBOT group. The percentage of patients undergoing surgery or receiving anticancer treatment did not differ significantly between the groups, whereas overall survival was significantly longer in the HBOT group. Furthermore, when examining inoperable patients, significantly more individuals in the HBOT group could resume eating, and their overall survival was significantly prolonged.

Conclusions: HBOT may increase the spontaneous resolution rate and improve long-term prognoses of patients with MBO secondary to peritoneal dissemination.

简介:本研究旨在探讨高压氧疗法对恶性肠梗阻(MBO)和腹膜播散患者的疗效:本研究旨在探讨高压氧疗法(HBOT)对恶性肠梗阻(MBO)合并腹膜播散患者的疗效:我们回顾性研究了高压氧治疗是否会影响伴有腹膜播散的恶性肠梗阻患者的预后。本研究纳入了 2013 年 1 月至 2022 年 12 月期间在我院确诊为继发于腹膜播散的 MBO 的 44 例患者。其中 30 名患者接受了 HBOT 治疗。治疗方案包括每天进行HBOT治疗,在2.5个绝对大气压下吸入100%氧气,持续60分钟:在对 HBOT 组和非 HBOT 组进行的单变量分析中,HBOT 组能恢复进食的患者比例明显更高。因此,非 HBOT 组 MBO 无改善的患者比例明显高于 HBOT 组。接受手术或抗癌治疗的患者比例在两组之间没有明显差异,而 HBOT 组的总生存期明显更长。此外,在对无法手术的患者进行检查时,HBOT 组中能恢复进食的患者明显更多,他们的总生存期也明显延长:HBOT可提高腹膜播散继发MBO患者的自发缓解率,改善长期预后。
{"title":"Effects of Hyperbaric Oxygen Therapy for Malignant Bowel Obstruction Caused by Peritoneal Dissemination.","authors":"Daisuke Muroya, Shoichiro Arai, Takamichi Nishida, Takahide Ishimaru, Yuta Yamazaki, Youjirou Goto, Shinya Nadayoshi, Yutaro Kai, Tetsu Masuda, Hisaaki Shimokobe, Yuichi Goto, Yuichi Nagao, Yoshito Wada, Takayuki Torigoe, Yoshinori Tomoda, Yuji Maruyama, Hajime Imada, Hironobu Sou, Yoshito Akagi, Toru Hisaka","doi":"10.2739/kurumemedj.MS7112001","DOIUrl":"10.2739/kurumemedj.MS7112001","url":null,"abstract":"<p><strong>Introduction: </strong>This study aimed to investigate the efficacy of hyperbaric oxygen therapy (HBOT) in patients presenting with malignant bowel obstruction (MBO) and peritoneal dissemination.</p><p><strong>Materials and methods: </strong>We retrospectively examined whether HBOT affects prognosis following MBO with peritoneal dissemination. This study included 44 patients diagnosed with MBO secondary to peritoneal dissemination at our hospital between January 2013 and December 2022. Among these patients, 30 underwent HBOT. The treatment protocol involved daily HBOT administration, comprising 100% oxygen at 2.5 atmospheres absolute for 60 min.</p><p><strong>Results: </strong>In a univariate analysis of HBOT and non-HBOT groups, the proportion of patients able to resume eating was significantly higher in the HBOT group. Therefore, the percentage of patients in the non-HBOT group whose MBO did not improve was significantly higher than that in the HBOT group. The percentage of patients undergoing surgery or receiving anticancer treatment did not differ significantly between the groups, whereas overall survival was significantly longer in the HBOT group. Furthermore, when examining inoperable patients, significantly more individuals in the HBOT group could resume eating, and their overall survival was significantly prolonged.</p><p><strong>Conclusions: </strong>HBOT may increase the spontaneous resolution rate and improve long-term prognoses of patients with MBO secondary to peritoneal dissemination.</p>","PeriodicalId":39559,"journal":{"name":"Kurume Medical Journal","volume":" ","pages":"19-28"},"PeriodicalIF":0.0,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142356010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High Expression of NDRG1 is a Poor Prognostic Factor in Patients with Endometrial Endometrioid Carcinoma with Long-Term Observation. NDRG1的高表达是长期观察子宫内膜样癌患者的不良预后因素
Q4 Medicine Pub Date : 2025-08-01 Epub Date: 2024-11-27 DOI: 10.2739/kurumemedj.MS7112004
Morio Ijichi, Kimio Ushijima, Tomohiko Yamaguchi, Naoyo Nishida, Kazuto Tasaki, Jongmyung Park, Shin Nishio, Toshiharu Kamura, Jun Akiba, Tatsuyuki Kakuma, Michihiko Kuwano, Naotake Tsuda

N-myc downstream regulated gene-1 (NDRG1) has attracted much attention as a protein associated with angiogenesis. This study investigated the associations of NDRG1 expression, determined by immunohistochemical analysis, with other clinicopathological factors and prognosis in patients with endometrial endometrioid carcinoma (EEC). Surgical specimens were obtained from 113 patients with EEC. High NDRG1 expression was correlated with advanced stage, poor differentiation, lymph node metastasis, and significantly poorer survival compared with patients with low expression. High expression of NDRG1 was also correlated with high levels of angiogenesis and low expression of the estrogen receptor. These results suggest that high expression of NDRG1 is associated with angiogenesis and is an indicator of a poor prognosis in women with EEC.

N-myc下游调控基因-1(NDRG1)作为一种与血管生成相关的蛋白备受关注。本研究调查了通过免疫组化分析确定的 NDRG1 表达与子宫内膜样癌(EEC)患者的其他临床病理因素和预后的关系。手术标本取自113例EEC患者。与低表达的患者相比,NDRG1的高表达与晚期、分化不良、淋巴结转移和生存率明显较低有关。NDRG1 的高表达还与高水平的血管生成和雌激素受体的低表达相关。这些结果表明,NDRG1的高表达与血管生成有关,是女性EEC患者预后不良的指标。
{"title":"High Expression of NDRG1 is a Poor Prognostic Factor in Patients with Endometrial Endometrioid Carcinoma with Long-Term Observation.","authors":"Morio Ijichi, Kimio Ushijima, Tomohiko Yamaguchi, Naoyo Nishida, Kazuto Tasaki, Jongmyung Park, Shin Nishio, Toshiharu Kamura, Jun Akiba, Tatsuyuki Kakuma, Michihiko Kuwano, Naotake Tsuda","doi":"10.2739/kurumemedj.MS7112004","DOIUrl":"10.2739/kurumemedj.MS7112004","url":null,"abstract":"<p><p>N-myc downstream regulated gene-1 (NDRG1) has attracted much attention as a protein associated with angiogenesis. This study investigated the associations of NDRG1 expression, determined by immunohistochemical analysis, with other clinicopathological factors and prognosis in patients with endometrial endometrioid carcinoma (EEC). Surgical specimens were obtained from 113 patients with EEC. High NDRG1 expression was correlated with advanced stage, poor differentiation, lymph node metastasis, and significantly poorer survival compared with patients with low expression. High expression of NDRG1 was also correlated with high levels of angiogenesis and low expression of the estrogen receptor. These results suggest that high expression of NDRG1 is associated with angiogenesis and is an indicator of a poor prognosis in women with EEC.</p>","PeriodicalId":39559,"journal":{"name":"Kurume Medical Journal","volume":" ","pages":"11-18"},"PeriodicalIF":0.0,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142740831","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Validity of High-Dose-Rate Interstitial Brachytherapy as Monotherapy for Mobile Tongue Cancer in Terms of the Acute Mucosal Reaction. 从急性黏膜反应角度看高剂量率间质近距离放射疗法作为移动性舌癌单一疗法的有效性
Q4 Medicine Pub Date : 2025-08-01 Epub Date: 2024-11-27 DOI: 10.2739/kurumemedj.MS7112003
Hironori Akiyama, Ken Yoshida, Tadayuki Kotsuma, Koji Masui, Tadashi Takenaka, Manabu Kano, Fumiaki Isohashi, Yuji Seo, Taiju Shimbo, Naoya Murakami, Yui Mori, Shinya Kotaki, Hitoshi Yoshimoto, Eiichi Tanaka, Nikolaos Tselis, Zoltán Takácsi-Nagy, Hideya Yamazaki, Satoaki Nakamura, Noboru Tanigawa, Kimishige Shimizutani, Kazuhiko Ogawa, Yoshiko Ariji

Background: The present study investigated the acute mucosal reaction (AMR) after high-dose-rate interstitial brachytherapy at 54 Gy/9 fractions (HDR54) as monotherapy administered twice a day for tongue cancer in 13 patients, and attempted to validate HDR54 by comparing the AMR with that of our previously reported HDR at 60 Gy/10 fractions (HDR60), and low-dose-rate interstitial brachytherapy at approximately 70 Gy (LDR70).

Methods: The European Organization for Research on Treatment of Cancer/ Radiation Therapy Oncology Group scoring system with modifications (score: 1-4.5) was used to evaluate AMR. The time courses of the AMR scores of HDR54 were recorded. The time courses of the AMR of HDR54, HDR 60, and LDR70 were each divided into 6 phases and compared.

Results: The number of cases in the HDR54 group with a lower score (1-2) at the time of the initial response was significantly higher (12 cases) than those in the HDR60 group (1 case) (p=0.0077) and LDR70 group (1 case) (p=0.0077). In the HDR54 group, the time between the end of treatment and appearance of the first response was significantly longer (median: 3 days) than those in the HDR60 group (median: 1 day) (p<0.001) and LDR70 group (median: 1 day) (p<0.001). No significant differences were observed in the maximum score, its duration, or other parameters.

Conclusions: The results indicated that the AMR of HDR54 started later and was gentler and more easily tolerated than the other two methods, suggesting the validity of HDR54 in terms of AMR.

背景:本研究调查了13例舌癌患者在接受54 Gy/9分次高剂量率间质近距离放射治疗(HDR54)后的急性粘膜反应(AMR),并尝试将AMR与我们之前报道的60 Gy/10分次高剂量率间质近距离放射治疗(HDR60)和约70 Gy的低剂量率间质近距离放射治疗(LDR70)进行比较,以验证HDR54的效果:方法:采用欧洲癌症治疗研究组织/肿瘤放疗组的评分系统进行 AMR 评估(评分:1-4.5)。记录了 HDR54 的 AMR 评分的时间进程。将 HDR54、HDR 60 和 LDR70 的 AMR 时间进程各分为 6 个阶段并进行比较:结果:HDR54 组初次反应时得分较低(1-2 分)的病例数(12 例)明显高于 HDR60 组(1 例)(P=0.0077)和 LDR70 组(1 例)(P=0.0077)。在 HDR54 组中,从治疗结束到出现首次反应的时间(中位数:3 天)明显长于 HDR60 组(中位数:1 天)(p 结论:结果表明,与其他两种方法相比,HDR54 的 AMR 开始得更晚,更温和,更容易耐受,这表明 HDR54 在 AMR 方面是有效的。
{"title":"Validity of High-Dose-Rate Interstitial Brachytherapy as Monotherapy for Mobile Tongue Cancer in Terms of the Acute Mucosal Reaction.","authors":"Hironori Akiyama, Ken Yoshida, Tadayuki Kotsuma, Koji Masui, Tadashi Takenaka, Manabu Kano, Fumiaki Isohashi, Yuji Seo, Taiju Shimbo, Naoya Murakami, Yui Mori, Shinya Kotaki, Hitoshi Yoshimoto, Eiichi Tanaka, Nikolaos Tselis, Zoltán Takácsi-Nagy, Hideya Yamazaki, Satoaki Nakamura, Noboru Tanigawa, Kimishige Shimizutani, Kazuhiko Ogawa, Yoshiko Ariji","doi":"10.2739/kurumemedj.MS7112003","DOIUrl":"10.2739/kurumemedj.MS7112003","url":null,"abstract":"<p><strong>Background: </strong>The present study investigated the acute mucosal reaction (AMR) after high-dose-rate interstitial brachytherapy at 54 Gy/9 fractions (HDR54) as monotherapy administered twice a day for tongue cancer in 13 patients, and attempted to validate HDR54 by comparing the AMR with that of our previously reported HDR at 60 Gy/10 fractions (HDR60), and low-dose-rate interstitial brachytherapy at approximately 70 Gy (LDR70).</p><p><strong>Methods: </strong>The European Organization for Research on Treatment of Cancer/ Radiation Therapy Oncology Group scoring system with modifications (score: 1-4.5) was used to evaluate AMR. The time courses of the AMR scores of HDR54 were recorded. The time courses of the AMR of HDR54, HDR 60, and LDR70 were each divided into 6 phases and compared.</p><p><strong>Results: </strong>The number of cases in the HDR54 group with a lower score (1-2) at the time of the initial response was significantly higher (12 cases) than those in the HDR60 group (1 case) (p=0.0077) and LDR70 group (1 case) (p=0.0077). In the HDR54 group, the time between the end of treatment and appearance of the first response was significantly longer (median: 3 days) than those in the HDR60 group (median: 1 day) (p<0.001) and LDR70 group (median: 1 day) (p<0.001). No significant differences were observed in the maximum score, its duration, or other parameters.</p><p><strong>Conclusions: </strong>The results indicated that the AMR of HDR54 started later and was gentler and more easily tolerated than the other two methods, suggesting the validity of HDR54 in terms of AMR.</p>","PeriodicalId":39559,"journal":{"name":"Kurume Medical Journal","volume":" ","pages":"29-36"},"PeriodicalIF":0.0,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142740880","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Upregulated Nuclear Y-box Binding Protein-1 Expression is Closely Associated with Mammalian Target of Rapamycin Expression in Endometrial Cancer. 细胞核Y-box结合蛋白-1表达上调与哺乳动物子宫内膜癌雷帕霉素靶蛋白表达密切相关
Q4 Medicine Pub Date : 2025-08-01 Epub Date: 2025-03-07 DOI: 10.2739/kurumemedj.MS7112011
Teruyuki Yoshimitsu, Shin Nishio, Jongmyung Park, Hiroki Nasu, Ken Matsukuma, Kazuto Tasaki, Takahiro Katsuda, Atsumu Terada, Kimio Ushijima, Naotake Tsuda, Akihiko Kawahara, Jun Akiba, Michihiko Kuwano

Enhanced oncogenic Y-box binding protein-1 (YB-1) expression, associated with the aberrant expression of genes involved in cell proliferation, survival, and drug resistance, can predict prognostic outcomes in patients with various malignancies. We examined whether YB-1 could predict prognostic outcomes in patients with endometrial cancer and whether enhanced YB-1 expression affects the expression of mammalian target of rapamycin (mTOR) in endometrial cancer. We examined the expression levels of YB-1 and mTOR in tumor samples of 166 patients with endometrial cancer, including those with endometrioid grade 1-3, serous carcinoma, and stage I-IV disease, who underwent surgery. The expression levels of both molecules were assessed using immunohistochemical analysis. The correlation between the expression levels of YB-1 or mTOR and prognosis was also confirmed.The positivity rate of nuclear YB-1 expression was 9.4%. YB-1 expression was associated with poor progression-free survival (P = 0.012) and overall survival (P = 0.003). Fifty-nine patients (35.5%) exhibited mTOR expression. Nuclear YB-1 expression was also correlated with mTOR expression (P = 0.006). We observed similar results when examining only patients who underwent adjuvant chemotherapy. Enhanced nuclear YB-1 expression could predict poor outcomes in endometrial cancer and was significantly associated with enhanced mTOR expression.

致癌Y-box结合蛋白-1 (YB-1)表达增强,与细胞增殖、存活和耐药相关基因的异常表达相关,可以预测各种恶性肿瘤患者的预后。我们研究了YB-1是否可以预测子宫内膜癌患者的预后,以及YB-1表达增强是否影响子宫内膜癌中哺乳动物雷帕霉素靶蛋白(mTOR)的表达。我们检测了166例子宫内膜癌患者的肿瘤样本中YB-1和mTOR的表达水平,包括那些接受手术的子宫内膜样1-3级、浆液性癌和I-IV期疾病。使用免疫组织化学分析评估这两种分子的表达水平。YB-1或mTOR表达水平与预后的相关性也得到证实。细胞核YB-1表达阳性率为9.4%。YB-1表达与较差的无进展生存期(P = 0.012)和总生存期(P = 0.003)相关。59例(35.5%)患者出现mTOR表达。细胞核中YB-1的表达也与mTOR表达相关(P = 0.006)。当只检查接受辅助化疗的患者时,我们观察到类似的结果。核YB-1表达增强可预测子宫内膜癌预后不良,并与mTOR表达增强显著相关。
{"title":"Upregulated Nuclear Y-box Binding Protein-1 Expression is Closely Associated with Mammalian Target of Rapamycin Expression in Endometrial Cancer.","authors":"Teruyuki Yoshimitsu, Shin Nishio, Jongmyung Park, Hiroki Nasu, Ken Matsukuma, Kazuto Tasaki, Takahiro Katsuda, Atsumu Terada, Kimio Ushijima, Naotake Tsuda, Akihiko Kawahara, Jun Akiba, Michihiko Kuwano","doi":"10.2739/kurumemedj.MS7112011","DOIUrl":"10.2739/kurumemedj.MS7112011","url":null,"abstract":"<p><p>Enhanced oncogenic Y-box binding protein-1 (YB-1) expression, associated with the aberrant expression of genes involved in cell proliferation, survival, and drug resistance, can predict prognostic outcomes in patients with various malignancies. We examined whether YB-1 could predict prognostic outcomes in patients with endometrial cancer and whether enhanced YB-1 expression affects the expression of mammalian target of rapamycin (mTOR) in endometrial cancer. We examined the expression levels of YB-1 and mTOR in tumor samples of 166 patients with endometrial cancer, including those with endometrioid grade 1-3, serous carcinoma, and stage I-IV disease, who underwent surgery. The expression levels of both molecules were assessed using immunohistochemical analysis. The correlation between the expression levels of YB-1 or mTOR and prognosis was also confirmed.The positivity rate of nuclear YB-1 expression was 9.4%. YB-1 expression was associated with poor progression-free survival (P = 0.012) and overall survival (P = 0.003). Fifty-nine patients (35.5%) exhibited mTOR expression. Nuclear YB-1 expression was also correlated with mTOR expression (P = 0.006). We observed similar results when examining only patients who underwent adjuvant chemotherapy. Enhanced nuclear YB-1 expression could predict poor outcomes in endometrial cancer and was significantly associated with enhanced mTOR expression.</p>","PeriodicalId":39559,"journal":{"name":"Kurume Medical Journal","volume":" ","pages":"51-60"},"PeriodicalIF":0.0,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143587560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Situs Inversus Totalis in Conjunction with an Anomalous Artery Connecting the Common Hepatic Artery and a Jejunal Branch of the Superior Mesenteric Artery: A Cadaveric Case Report. 完全性倒位与连接肝总动脉和肠系膜上动脉空肠分支的异常动脉联合:一例尸体病例报告。
Q4 Medicine Pub Date : 2025-08-01 Epub Date: 2025-03-07 DOI: 10.2739/kurumemedj.MS7112010
Azumi Yano, Aya Han, Yoko Tabira, Keishiro Kikuchi, Yuto Haikata, Tatsuya Harano, Keigo Shimizu, Eiko Inoue, Kunimitsu Nooma, Joe Iwanaga, Tsuyoshi Saga, Koichi Watanabe

We encountered a case of situs inversus totalis in conjunction with an anomalous artery connecting the common hepatic artery and a jejunal branch of the superior mesenteric artery during anatomical dissection of a cadaver. The heart was located in the center of the thorax, with the apex located anterioinferiorly to the right of the midline and the base located posterosuperiorly to the left of the midline. The aortic arch coursed from right anterior to right posterior. The right lung was divided into two lobes, and the left lung was divided into three. The entire intraperitoneal gastrointestinal tract, from the stomach to the rectum, formed a mirror image with the expected normal anatomy. The liver was located on the left side of the upper abdominal cavity, and the spleen was located on the right. The cardia of the stomach was located on the right side, and the pylorus was on the left. The cecum and appendix were located on the left, and the sigmoid colon ran toward the pelvic cavity from the right. In addition to situs inversus totalis, an anomalous artery called the arc of Bühler that branched off the common hepatic artery and entered the mesenteric arcade between the first and second jejunal arteries was observed. These anomalies were not embryologically related and occurred separately from each other. However, their presence may cause confusion during abdominal surgery. Knowledge of this specific combination of anatomical variations may help surgeons who encounter it in clinical practice.

我们在解剖尸体的过程中遇到了一例完全性倒位与连接肝总动脉和肠系膜上动脉空肠分支的异常动脉相结合的病例。心脏位于胸腔正中,心尖位于中线右前方下方,基底位于中线左后方上方。主动脉弓从右前走向右后。右肺分为两叶,左肺分为三叶。整个腹膜内胃肠道,从胃到直肠,与预期的正常解剖结构形成镜像。肝脏位于上腹腔左侧,脾脏位于右侧。贲门位于右侧,幽门位于左侧。盲肠和阑尾位于左侧,乙状结肠从右侧走向盆腔。除完全性倒位外,还观察到一条从肝总动脉分叉并进入第一和第二空肠动脉之间的肠系膜拱廊的异常动脉,称为bhler弧。这些异常与胚胎学无关,彼此分开发生。然而,它们的存在可能会在腹部手术中引起混乱。了解这种特殊的解剖变异组合可以帮助外科医生在临床实践中遇到这种情况。
{"title":"Situs Inversus Totalis in Conjunction with an Anomalous Artery Connecting the Common Hepatic Artery and a Jejunal Branch of the Superior Mesenteric Artery: A Cadaveric Case Report.","authors":"Azumi Yano, Aya Han, Yoko Tabira, Keishiro Kikuchi, Yuto Haikata, Tatsuya Harano, Keigo Shimizu, Eiko Inoue, Kunimitsu Nooma, Joe Iwanaga, Tsuyoshi Saga, Koichi Watanabe","doi":"10.2739/kurumemedj.MS7112010","DOIUrl":"10.2739/kurumemedj.MS7112010","url":null,"abstract":"<p><p>We encountered a case of situs inversus totalis in conjunction with an anomalous artery connecting the common hepatic artery and a jejunal branch of the superior mesenteric artery during anatomical dissection of a cadaver. The heart was located in the center of the thorax, with the apex located anterioinferiorly to the right of the midline and the base located posterosuperiorly to the left of the midline. The aortic arch coursed from right anterior to right posterior. The right lung was divided into two lobes, and the left lung was divided into three. The entire intraperitoneal gastrointestinal tract, from the stomach to the rectum, formed a mirror image with the expected normal anatomy. The liver was located on the left side of the upper abdominal cavity, and the spleen was located on the right. The cardia of the stomach was located on the right side, and the pylorus was on the left. The cecum and appendix were located on the left, and the sigmoid colon ran toward the pelvic cavity from the right. In addition to situs inversus totalis, an anomalous artery called the arc of Bühler that branched off the common hepatic artery and entered the mesenteric arcade between the first and second jejunal arteries was observed. These anomalies were not embryologically related and occurred separately from each other. However, their presence may cause confusion during abdominal surgery. Knowledge of this specific combination of anatomical variations may help surgeons who encounter it in clinical practice.</p>","PeriodicalId":39559,"journal":{"name":"Kurume Medical Journal","volume":" ","pages":"79-83"},"PeriodicalIF":0.0,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143587559","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Case of Sarcoid Reaction in Subcarinal Lymph Node in A Postoperative Breast Cancer Diagnosed by Thoracoscopic Biopsy. 一例通过胸腔镜活检确诊的乳腺癌术后心包下淋巴结肉样瘤反应病例
Q4 Medicine Pub Date : 2025-08-01 Epub Date: 2024-11-27 DOI: 10.2739/kurumemedj.MS7112009
Kunihiro Ozaki, Shintaro Yokoyama, Toshihiro Hashiguchi, Kensuke Tajiri, Kou Shigemura, Daigo Murakami, Yutaka Nishimura, Maki Tanaka, Ryouzou Hayashida, Fumihiko Fujita

Lymph node recurrence is common in patients with breast cancer, and breast surgeons often diagnose it based solely on computed tomography (CT) or fluorine-18 fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT). In this case report, we present a patient with breast cancer having a false positive lymph node detected by FDG-PET/CT, which was later identified as a sarcoid reaction through thoracoscopic surgery. This pathological diagnosis allowed the patient to avoid unnecessary long-term cancer therapies, such as chemotherapy and hormone therapy. In conclusion, lymph nodes in patients with breast cancer should undergo pathological diagnosis, and thoracoscopic surgery is a valuable approach for accurate diagnosis, even when FDG-PET/CT shows positive results.

淋巴结复发在乳腺癌患者中很常见,乳腺外科医生通常仅根据计算机断层扫描(CT)或氟-18 氟脱氧葡萄糖正电子发射断层扫描-计算机断层扫描(FDG-PET/CT)来诊断淋巴结复发。在本病例报告中,我们介绍了一名通过 FDG-PET/CT 检测出淋巴结假阳性的乳腺癌患者,后来通过胸腔镜手术确定其为肉瘤反应。这一病理诊断使患者避免了不必要的长期癌症治疗,如化疗和激素治疗。总之,乳腺癌患者的淋巴结应接受病理诊断,即使FDG-PET/CT显示阳性结果,胸腔镜手术也是准确诊断的重要方法。
{"title":"A Case of Sarcoid Reaction in Subcarinal Lymph Node in A Postoperative Breast Cancer Diagnosed by Thoracoscopic Biopsy.","authors":"Kunihiro Ozaki, Shintaro Yokoyama, Toshihiro Hashiguchi, Kensuke Tajiri, Kou Shigemura, Daigo Murakami, Yutaka Nishimura, Maki Tanaka, Ryouzou Hayashida, Fumihiko Fujita","doi":"10.2739/kurumemedj.MS7112009","DOIUrl":"10.2739/kurumemedj.MS7112009","url":null,"abstract":"<p><p>Lymph node recurrence is common in patients with breast cancer, and breast surgeons often diagnose it based solely on computed tomography (CT) or fluorine-18 fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT). In this case report, we present a patient with breast cancer having a false positive lymph node detected by FDG-PET/CT, which was later identified as a sarcoid reaction through thoracoscopic surgery. This pathological diagnosis allowed the patient to avoid unnecessary long-term cancer therapies, such as chemotherapy and hormone therapy. In conclusion, lymph nodes in patients with breast cancer should undergo pathological diagnosis, and thoracoscopic surgery is a valuable approach for accurate diagnosis, even when FDG-PET/CT shows positive results.</p>","PeriodicalId":39559,"journal":{"name":"Kurume Medical Journal","volume":" ","pages":"85-88"},"PeriodicalIF":0.0,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142740771","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Kurume Medical Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1